NASDAQ
In Veritas Medical Diagnostics, Inc. (IVMED) has a free cash flow growth of -151.78% as of Monday, June 15, 2026. This represents a 1063.55% decrease compared to its 12-month average of -13.04%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.